Literature DB >> 24133607

Malignant perivascular epithelioid cell tumor of the retroperitoneum.

Ji-Hua Wu1, Jin-Lian Zhou, Yan Cui, Qing-Ping Jing, Le Shang, Jian-Zhong Zhang.   

Abstract

Perivascular epithelioid cell tumors (PEComas) are a rare type of mesenchymal neoplasms characterized by a proliferation of perivascular cells with an epithelioid phenotype and expression of myo-melanocytic markers. The majority of PEComas seem to be benign and usually their prognosis is good. Malignant cases are extremely rare, exhibiting a malignant course with local recurrences and distant metastases. We herein report a case of a malignant PEComa arising in the retroperitoneum. The patient was a 55-year-old woman experiencing abdominal discomfort for approximately one month. Ultrasound and computer tomography (CT) scans of the abdomen revealed a solid mass arising from the retroperitoneum. Microscopically, the tumor was composed of epithelioid cells mixed with spindled cells. The nucleus had significant atypia, and the mitoses were obvious. The focal intravascular tumor embolus was visible. Immunohistochemically, the epithelioid tumor cells were positive for HMB45 and Melan-A, and the spindled tumor celLs were positive for SMA and desmin. Seven months after a surgical resection, an ultrasound revealed liver metastases. In conclusion, the malignant PEComas of the retroperitoneum is a very rare neoplasm with unique morphological and immunohistochemical characteristics. It should be differentiated from other epithelioid cell tumors of the retroperitoneum.

Entities:  

Keywords:  Retroperitoneum; clinicopathology; perivascular epithelioid cell tumors

Mesh:

Year:  2013        PMID: 24133607      PMCID: PMC3796251     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

Review 1.  Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.

Authors:  Andrew L Folpe; Thomas Mentzel; Hans-Anton Lehr; Cyril Fisher; Bonnie L Balzer; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

2.  Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis.

Authors:  F Bonetti; G Martignoni; C Colato; E Manfrin; M Gambacorta; M Faleri; C Bacchi; V C Sin; N L Wong; M Coady; J K Chan
Journal:  Mod Pathol       Date:  2001-06       Impact factor: 7.842

Review 3.  Extrarenal retroperitoneal angiomyolipoma: case report and review of the literature.

Authors:  C-A Tseng; Y-S Pan; Y-C Su; D-C Wu; C-M Jan; W-M Wang
Journal:  Abdom Imaging       Date:  2004-06-08

4.  Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum.

Authors:  Jason L Hornick; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2008-04       Impact factor: 6.394

5.  Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.

Authors:  Andrew J Wagner; Izabela Malinowska-Kolodziej; Jeffrey A Morgan; Wei Qin; Christopher D M Fletcher; Natalie Vena; Azra H Ligon; Cristina R Antonescu; Nikhil H Ramaiya; George D Demetri; David J Kwiatkowski; Robert G Maki
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

6.  Malignant perivascular epithelioid cell tumor of the uterus.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Rare Tumors       Date:  2012-03-12

7.  "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Sarcoma       Date:  2012-04-26

Review 8.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

Review 9.  Malignant perivascular epithelioid cell tumor of mesentery with lymph node involvement: a case report and review of literature.

Authors:  Xinge Fu; Ju-hong Jiang; Xia Gu; Zhi Li
Journal:  Diagn Pathol       Date:  2013-04-15       Impact factor: 2.644

10.  Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor.

Authors:  Constantine Gennatas; Vasiliki Michalaki; Paraskevi Vasilatou Kairi; Agathi Kondi-Paphiti; Dionysios Voros
Journal:  World J Surg Oncol       Date:  2012-09-03       Impact factor: 2.754

View more
  4 in total

1.  PEComa of the terminal ileum mesentery as a secondary tumour in an adult survivor of embryonal rhabdomyosarcoma.

Authors:  H Hasan; A F Howard; A H Alassiri; T L Ng; G McGregor; K Goddard
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

2.  Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa.

Authors:  Fang Gao; Chengsuo Huang; Yiping Zhang; Ruirui Sun; Yujie Zhang; Huijun Wang; Shu Zhang
Journal:  Cancer Biol Ther       Date:  2016-03-30       Impact factor: 4.742

3.  Retroperitoneal perivascular epithelioid cell tumours: A case report and review of literature.

Authors:  Zisis Touloumis; Niki Giannakou; Christos Sioros; Argiro Trigka; Maria Cheilakea; Nikoletta Dimitriou; John Griniatsos
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

Review 4.  Hepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation: A case report and literature review.

Authors:  Haitao Guan; Yinghua Zou; Yongxing Lv; Chao Wang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.